Ronan Abgral - Concepedia

Author

Ronan Abgral

Centre Hospitalier Régional Universitaire de Brest ORCID

Also Known As

Abgral, Ronan, R. Abgral, Ronan ABGRAL, Ronan Abgral

249

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Régional Universitaire de Brest Université de Bretagne Occidentale Inserm Université Européenne de Bretagne Laboratoire de Traitement de l'Information Médicale

About

Ronan Abgral is an author at Centre Hospitalier Régional Universitaire de Brest specializing in radiology, medical imaging, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	14	14	758
2	Medicine	13	13	682
3	Engineering	2	2	42
4	Public Health	2	2	96
5	Biomedical Engineering	1	1	22

Ronan Abgral

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Does <sup>18</sup>F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up? Ronan Abgral, S. Querellou, G. Potard, Journal of Nuclear Medicine	2008	241
Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis Marc R. Dweck, Ronan Abgral, Maria Giovanna Trivieri, JACC. Cardiovascular imaging Positron Emission TomographyHealth SciencesMedical ImagingPet-mriPathology	2017	190
Pretreatment <sup>18</sup>F-FDG PET/CT Radiomics Predict Local Recurrence in Patients Treated with Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer: A Multicentric Study Gurvan Dissaux, Dimitris Visvikis, Ronrick Da‐ano, Journal of Nuclear Medicine	2019	161
Good clinical practice recommendations for the use of PET/CT in oncology Pierre‐Yves Salaün, Ronan Abgral, O. Malard, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyOncologic ImagingMedical ImagingPet-mriOncology	2019	135
Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging Ronan Abgral, Sophie Leboulleux, Désirèe Deandreis, The Journal of Clinical Endocrinology & Metabolism	2010	107
Coronary Artery PET/MR Imaging Philip M. Robson, Marc R. Dweck, Maria Giovanna Trivieri, JACC. Cardiovascular imaging Vascular ImageHealth SciencesMedical ImagingAtherosclerosisPet-mri	2017	102
Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma Ronan Abgral, Nathalie Keromnes, Philippe Robin, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission Tomography18F-fdg Pet/ctMedical ImagingMedicinePet-mri	2013	64
Value of 18F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment Xavier Palard-Novello, S. Querellou, Maëlenn Gouillou, European Journal of Nuclear Medicine and Molecular Imaging Rheumatology18F-fdg Pet/ctTherapeutic AssessmentRheumatic DiseasesFibromyalgia	2016	62
First‐line pembrolizumab for non–small cell lung cancer patients with PD‐L1 ≥50% in a multicenter real‐life cohort: The PEMBREIZH study Karim Amrane, Margaux Geier, R. Corre, Cancer Medicine	2020	60
Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease Ronan Abgral, Marc R. Dweck, Maria Giovanna Trivieri, JACC. Cardiovascular imaging Combined Fdg-pet/mrCardiovascular DiseaseMedical ImagingPet-mriMyocardial Infarction	2016	59

Page 1